Any feedback?
Literature summary for 5.4.2.11 extracted from
- High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases (2010), J. Neuroimmunol., 219, 105-108.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | the anti-PGAM1 antibody is a marker of autoimmune hepatitis and a nonspecific marker of central nervous system autoimmune diseases | Rattus norvegicus |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2-phospho-D-glycerate | Rattus norvegicus | - |
3-phospho-D-glycerate | - |
? |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| brain | - |
Rattus norvegicus | - |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| 2-phospho-D-glycerate | - |
Rattus norvegicus | 3-phospho-D-glycerate | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PGAM1 | - |
Rattus norvegicus |
| phosphoglycerate mutase 1 | - |
Rattus norvegicus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
